NSCLC Patients Harbouring Rare or Complex EGFR Mutations Are More Often Smokers and Might Not Benefit from First-Line Tyrosine Kinase Inhibitor Therapy
Kauffmann-Guerrero, Diego, Huber, Rudolf Maria, Reu, Simone, Tufman, Amanda, Mertsch, Pontus, Syunyaeva, Zulfiya, Jung, Andreas, Kahnert, KathrinLanguage:
english
Journal:
Respiration
DOI:
10.1159/000484175
Date:
November, 2017
File:
PDF, 287 KB
english, 2017